OnKure, Inc. Raises $55 Million Series B Financing

06 Mar, 2021

OnKure, Inc. Raises $55 Million Series B Financing
Photo by Raphael Koh on Unsplash

– OnKure, Inc. raised $55m in a Series B financing.
– Proceeds will be used to advance the Company’s next generation histone deacetylase (HDAC) inhibitors further into clinical development and fund a growing pipeline of earlier stage molecules.
– The financing was led by Acorn Bioventures with participation from additional new investors Cormorant Asset Management, Surveyor Capital (a Citadel company), Samsara BioCapital, Perceptive Advisors and funds and accounts managed by BlackRock.
– In connection with the financing, Isaac Manke, Ph.D., Partner at Acorn Bioventures, and Andrew Phillips, Ph.D., Managing Director at Cormorant Asset Management, will join the OnKure board of directors.

Biotechnology Life Science North America Therapeutics
Crunchbase icon

Content report

The following text will be sent to our editors: